Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab

被引：0

作者：

Nash, Peter ^{[1
]}

McInnes, Iain ^{[2
]}

Ritchlin, Christopher T. ^{[3
]}

Tam, Lai-Shan ^{[4
]}

Soriano, Enrique ^{[5
,6
]}

Starr, Michael ^{[7
]}

Rampakakis, Emmanouil ^{[8
]}

Lavie, Frederic ^{[9
]}

Shawi, May ^{[10
]}

Baraliakos, Xenofon ^{[11
]}

Mease, Philip J. ^{[12
,13
]}

机构：

[1] Griffith Univ, Sch Med, Brisbane, Qld, Australia

[2] Univ Glasgow, Glasgow, Lanark, Scotland

[3] Univ Rochester, Med Ctr, Dept Med Allergy Immunol & Rheumatol, Rochester, NY 14642 USA

[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[5] Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Sect, Buenos Aires, DF, Argentina

[6] Univ Inst Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[7] McGill Univ, Hlth Ctr, Div Rheumatol, Montreal, PQ, Canada

[8] McGill Univ, Dept Pediat, JSS Med Res, Sci Affairs, Montreal, PQ, Canada

[9] Janssen Pharmaceut Co Johnson & Johnson, Paris, France

[10] Janssen Res & Dev LLC, Immunol, Titusville, NJ USA

[11] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany

[12] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[13] Univ Washington, Sch Med, Seattle, WA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

BIOLOGIC-NAIVE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1419

引用

页码：2785 / 2787

页数：3

共 50 条

[31] Safety of tildrakizumab in psoriatic arthritis: An interim analysis from a randomized, double-blind, placebo-controlled phase 2b trial
Ritchlin, Christopher T.
Strand, Vibeke
Ballerini, Rocco
Chou, Richard
Rozzo, Stephen J.
Mendelsohn, Alan M.
Kavanaugh, Arthur
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB166 - AB166
[32] Safety of Tildrakizumab in Psoriatic Arthritis: An Interim Analysis from a Randomized, Double-blind, Placebo-controlled Phase 2b Trial
Ritchlin, Christopher
Strand, Vibeke
Ballerini, Rocco
Chou, Richard C.
Rozzo, Stephen
Mendelsohn, Alan
Kavanaugh, Arthur
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[33] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
Pariser, David M.
Bagel, Jerry
Lebwohl, Mark
Yosipovitch, Gil
Chien, Elaine
Spellman, Mary C.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
[34] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
CARETTE, S
CALIN, A
MCCAFFERTY, JP
WALLIN, BA
ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
[35] EFFICACY AND SAFETY OF GUSELKUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE AXIAL PSORIATIC ARTHRITIS: STUDY DESIGN OF A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Gladman, D. D.
Mease, P. J.
Bird, P.
Soriano, E.
Chakravarty, S. D.
Shawi, M.
Xu, S.
Quinn, S.
Gong, C.
Leibowitz, E.
Tam, L. S.
Helliwell, P.
Kavanaugh, A.
Deodhar, A.
Ostergaard, M.
Baraliakos, X.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1574 - 1575
[36] GOLIMUMAB 3-YEAR SAFETY UPDATE: AN ANALYSIS OF POOLED DATA FROM THE LONG TERM EXTENSIONS OF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
Kay, J.
Fleischmann, R.
Keystone, E.
Hsia, E. C.
Doyle, M. K.
Hsu, B.
Mack, M.
Beutler, A.
Braun, J.
Kavanaugh, A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 515 - 516
[37] Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
Deodhar, Atul A.
Gottlieb, Alice B.
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Zhuang, Yanli
Barchuk, William
Xu, Xie L.
Hsia, Elizabeth
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[38] SULFASALAZINE THERAPY FOR PSORIATIC-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
GUPTA, AK
GROBER, JS
HAMILTON, TA
ELLIS, CN
SIEGEL, MT
VOORHEES, JJ
MCCUNE, WJ
JOURNAL OF RHEUMATOLOGY, 1995, 22 (05) : 894 - 898
[39] Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Hilton, Said
Kestemont, Philippe
Sattler, Gerhard
Volteau, Magali
Thompson, Catherine
Andriopoulos, Bill
Prygova, Inna
Berg, Anna-Karin
Ascher, Benjamin
DERMATOLOGIC SURGERY, 2022, 48 (11) : 1198 - 1202
[40] FUMARIC-ACID THERAPY FOR PSORIATIC-ARTHRITIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
PEETERS, AJ
DIJKMANS, BAC
VANDERSCHROEFF, JG
BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (07): : 502 - 504

← 1 2 3 4 5 →